Academic Journal
Quartile not availableJournal of Oncology
About Journal of Oncology
About Journal of Oncology
Journal of Oncology is a peer-reviewed scholarly journal published by Hindawi Publishing Corporation.
Key indicators: ISSN 16878450, 16878469.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
Publishing in Journal of Oncology
When considering this journal, verify its current indexing status, editorial board, and recent publications to ensure it meets your needs for visibility and credibility.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
- Submission: Submit via the official journal website.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of Journal of Oncology?
16878450, 16878469.
Who publishes Journal of Oncology?
Hindawi Publishing Corporation.
Where do I submit to Journal of Oncology?
Via the official website.
Is Journal of Oncology peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Journal Metrics
A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Correction to “Initial Report on Differential Expression of Sprouty Proteins 1 and 2 in Human Epithelial Ovarian Cancer Cell Lines”
2026-01 · DOI: 10.1155/jo/9813231RETRACTION: β ‐Elemene Restrains PTEN mRNA Degradation to Restrain the Growth of Lung Cancer Cells via METTL3‐Mediated N 6 Methyladenosine Modification
Journal of Oncology
2026-01 · DOI: 10.1155/jo/9839181RETRACTION: All‐Trans Retinoic Acid Enhances Chemosensitivity to 5‐FU by Targeting miR‐378c/E2F7 Axis in Colorectal Cancer
Journal of Oncology
2026-01 · DOI: 10.1155/jo/9824048RETRACTION: P4HA2 Promotes Epithelial‐to‐Mesenchymal Transition and Glioma Malignancy through the Collagen‐Dependent PI3K/AKT Pathway
Journal of Oncology
2026-01 · DOI: 10.1155/jo/9783154Correction to “Neutrophil‐Lymphocyte Ratio as a Prognostic Parameter in NSCLC Patients Receiving EGFR‐TKIs: A Systematic Review and Meta‐Analysis”
2026-01 · DOI: 10.1155/jo/9826802RETRACTION: Nrf3 Promotes 5‐FU Resistance in Colorectal Cancer Cells via the NF‐κB/BCL‐2 Signaling Pathway In Vitro and In Vivo
Journal of Oncology
2026-01 · DOI: 10.1155/jo/9754059RETRACTION: miR‐135a Targets SMAD2 to Promote Osteosarcoma Proliferation and Migration
Journal of Oncology
2026-01 · DOI: 10.1155/jo/9794048Correction to “Clusterin Silencing in Prostate Cancer Induces Matrix Metalloproteinases by an NF‐κB‐Dependent Mechanism”
2026-01 · DOI: 10.1155/jo/9894523RETRACTION: Cancer‐Associated Fibroblast‐Derived Exosomal miRNA‐320a Promotes Macrophage M2 Polarization In Vitro by Regulating PTEN/PI3Kγ Signaling in Pancreatic Cancer
Journal of Oncology
2026-01 · DOI: 10.1155/jo/9845393Correction to “A Pan‐Cancer Analysis on the Systematic Correlation of MutS Homolog 2 (MSH2) to a Malignant Tumor”
2026-01 · DOI: 10.1155/jo/9756191RETRACTION: Construction and Verification of a Novel Pyroptosis‐Related lncRNA Signature Associated with Immune Landscape in Gliomas
Journal of Oncology
2026-01 · DOI: 10.1155/jo/9842864RETRACTION: Comparison Efficacy and Safety of Gemcitabine plus Cisplatin and 5‐Fluorouracil plus Cisplatin for Metastatic Nasopharyngeal Carcinoma: A Meta‐Analysis and Systematic Review
Journal of Oncology
2026-01 · DOI: 10.1155/jo/9832316Correction to “Prospective Evaluation of Complications and Associated Risk Factors in Breast Cancer Surgery”
2026-01 · DOI: 10.1155/jo/9805269RETRACTION: Long Noncoding RNA NR2F1‐AS1 Enhances the Migration and Invasion of Hepatocellular Carcinoma via Modulating miR‐642a/DEK Pathway
Journal of Oncology
2026-01 · DOI: 10.1155/jo/9759101RETRACTION: Prp19 Facilitated p21‐Dependent Senescence of Hepatocellular Carcinoma Cells
Journal of Oncology
2026-01 · DOI: 10.1155/jo/9870183RETRACTION: Bee Venom Triggers Autophagy‐Induced Apoptosis in Human Lung Cancer Cells via the mTOR Signaling Pathway
Journal of Oncology
2025-01 · DOI: 10.1155/jo/9808753RETRACTION: MiR‐223 Promotes Tumor Progression via Targeting RhoB in Gastric Cancer
Journal of Oncology
2025-01 · DOI: 10.1155/jo/9798674RETRACTION: LncRNA NKILA Promotes Epithelial‐Mesenchymal Transition of Liver Cancer Cells by Targeting miR‐485‐5p
Journal of Oncology
2025-01 · DOI: 10.1155/jo/9874094RETRACTION: Chelerythrine Inhibits Stemness of Cancer Stem‐Like Cells of Osteosarcoma and PI3K/AKT/mTOR Signal
Journal of Oncology
2025-01 · DOI: 10.1155/jo/9832873Reviews
Community Reviews
Version History
October 10, 2026 at 7:22 pm
October 9, 2026